pharmaphorum

MARCH 11, 2022

After a period where vaccine development had fallen away, suddenly it is back in the limelight. However, for those individuals working on vaccine development, the pandemic has proven to be a validation of the important work being carried out in the field. billion from its vaccine in 2021. The ‘poor relation’.

Vaccines 81

Vaccines Diabetes Hospitals 81

Pharmaceutical Technology

MAY 15, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Diabetes 52

Diabetes Hospitals Immunization Immunity 52

PharmaShots

APRIL 12, 2023

Total Revenue: $23.86B Founded Year: 1668 Total Employees: ~64,200 Headquarters: Darmstadt, Germany Market Cap: $24.75B Stock Exchange: ETR A science and technology company, Merck KGaA is a prominent name in developing therapeutic options targeting areas including Cardiovascular, Diabetes, Oncology, Neurology, and Immunology.

Diabetes 64

Diabetes Vaccines Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Compounding 52

Compounding Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

JANUARY 31, 2023

Founded Year: 2010 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. Funding Value: $9.6M of Shares: 2.3M Funding Value: $15.9M

Vaccines 40

Vaccines Immunity Immunization Diabetes 40

The Thyroid Pharmacist

NOVEMBER 8, 2024

15] Researchers believe that infections such as MAP might be a common pathogenic trigger behind multiple autoimmune and other diseases (including Hashimoto’s, rheumatoid arthritis, Crohn’s disease, type 1 diabetes, and possibly psoriasis) in genetically susceptible individuals. [16] In one study, genetically susceptible mice with E.

Immunity 77

Immunity Immunization Diabetes Adverse Reactions 77